| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NextCell Pharma AB (ST: NXTCL)
NXTCL Technical Analysis
5
| As on 24th Apr 2025 NXTCL SHARE Price closed @ 1.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.16 & Strong Sell for SHORT-TERM with Stoploss of 2.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NXTCLSHARE Price
| Open | 1.16 | Change | Price | % |
| High | 1.44 | 1 Day | 0.15 | 15.00 |
| Low | 1.00 | 1 Week | 0.08 | 7.48 |
| Close | 1.15 | 1 Month | -2.03 | -63.84 |
| Volume | 781491 | 1 Year | -1.84 | -61.54 |
| 52 Week High 3.80 | 52 Week Low 0.81 | ||||
ST Sweden Most Active Stocks
| FING-B | 0.01 | 0.00% |
| WYLD | 0.05 | 0.00% |
| SBB-B | 3.86 | -0.52% |
| LUNE | 21.97 | 6.65% |
| TELIA | 35.44 | 0.65% |
| QUIA | 0.01 | 0.00% |
| HDW-B | 0.00 | % |
| QLINEA | 0.04 | 0.00% |
| ENERS | 0.00 | % |
| EURA | 0.01 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| NXTCL Daily Charts |
NXTCL Intraday Charts |
Whats New @ Bazaartrend |
NXTCL Free Analysis |
|
|
NXTCL Important Levels Intraday
| RESISTANCE | 2.00 |
| RESISTANCE | 1.73 |
| RESISTANCE | 1.56 |
| RESISTANCE | 1.39 |
| SUPPORT | 0.91 |
| SUPPORT | 0.74 |
| SUPPORT | 0.57 |
| SUPPORT | 0.30 |
NXTCL Forecast April 2025
| 4th UP Forecast | 3.27 |
| 3rd UP Forecast | 2.59 |
| 2nd UP Forecast | 2.17 |
| 1st UP Forecast | 1.75 |
| 1st DOWN Forecast | 0.55 |
| 2nd DOWN Forecast | 0.13 |
| 3rd DOWN Forecast | -0.29 |
| 4th DOWN Forecast | -0.97 |
NXTCL Weekly Forecast
| 4th UP Forecast | 1.90 |
| 3rd UP Forecast | 1.66 |
| 2nd UP Forecast | 1.51 |
| 1st UP Forecast | 1.36 |
| 1st DOWN Forecast | 0.94 |
| 2nd DOWN Forecast | 0.79 |
| 3rd DOWN Forecast | 0.64 |
| 4th DOWN Forecast | 0.40 |
NXTCL Forecast2025
| 4th UP Forecast | 7.59 |
| 3rd UP Forecast | 5.52 |
| 2nd UP Forecast | 4.25 |
| 1st UP Forecast | 2.97 |
| 1st DOWN Forecast | -0.67 |
| 2nd DOWN Forecast | -1.95 |
| 3rd DOWN Forecast | -3.22 |
| 4th DOWN Forecast | -5.29 |
NextCell Pharma AB ( ST Sweden Symbol : NXTCL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NXTCL Business Profile
NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. The company develops ProTrans, a drug candidate comprising stem cells primarily for treating autoimmune and inflammatory diseases, as well as for use in kidney transplants. It also provides a service under the Cellaviva brand name, which is a stem cell bank for the family-saving of stem cells from umbilical cord blood and umbilical cord tissue. The company has a partnership with Bonzun Health Information AB. NextCell Pharma AB was founded in 2014 and is based in Huddinge, Sweden. Address: Karolinska Institutet Science Park, Huddinge, Sweden, 141 57
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service